Gallbladder Cancer in the 21st Century

Table 5

Results of three phase 2 trials which exclusively evaluated efficacy of chemotherapy in patients with advanced gall bladder cancer.

Regimen	Number of patients	Response rate (%)	Median overall survival
Gemcitabine monotherapy [107]	26	36	30 weeks
Gemcitabine and cisplatin [106]	30	37	20 weeks
Gemcitabine and cisplatin [108]	42	48	7 months

Modified from [2].